Péter Ágoston

668 total citations
30 papers, 103 citations indexed

About

Péter Ágoston is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Péter Ágoston has authored 30 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 6 papers in Oncology. Recurrent topics in Péter Ágoston's work include Prostate Cancer Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (13 papers) and Prostate Cancer Treatment and Research (13 papers). Péter Ágoston is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (13 papers) and Prostate Cancer Treatment and Research (13 papers). Péter Ágoston collaborates with scholars based in Hungary, France and Australia. Péter Ágoston's co-authors include Csaba Polgár, Tibor Major, Zoltán Takácsi‐Nagy, Georgina Fröhlich, Sébastien Carrère, Víctor Moreno, Marco Rastrelli, Esma Saâda, Zoltán Mátrai and Antonio Casado and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Péter Ágoston

26 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Ágoston Hungary 5 84 56 20 11 11 30 103
Rodrigo Hepp Germany 5 59 0.7× 42 0.8× 15 0.8× 9 0.8× 13 1.2× 9 95
Philip Camilleri United Kingdom 7 65 0.8× 29 0.5× 18 0.9× 17 1.5× 20 1.8× 11 97
Mary Ellen Masterson-McGary United States 3 106 1.3× 97 1.7× 20 1.0× 13 1.2× 2 0.2× 6 124
J.K. Wong United States 6 57 0.7× 26 0.5× 15 0.8× 17 1.5× 21 1.9× 18 84
Piotr Piasecki Poland 6 35 0.4× 18 0.3× 27 1.4× 19 1.7× 6 0.5× 31 118
L. Ciurlionis United Kingdom 6 40 0.5× 72 1.3× 61 3.0× 19 1.7× 7 0.6× 7 118
Audrey Dang United States 5 65 0.8× 66 1.2× 48 2.4× 8 0.7× 10 0.9× 9 102
Jos Immerzeel Netherlands 7 63 0.8× 46 0.8× 36 1.8× 33 3.0× 23 2.1× 11 126
L. Bower United Kingdom 5 89 1.1× 112 2.0× 87 4.3× 17 1.5× 6 0.5× 8 139
Christine Elder New Zealand 4 35 0.4× 40 0.7× 33 1.6× 25 2.3× 14 1.3× 6 75

Countries citing papers authored by Péter Ágoston

Since Specialization
Citations

This map shows the geographic impact of Péter Ágoston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Ágoston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Ágoston more than expected).

Fields of papers citing papers by Péter Ágoston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Ágoston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Ágoston. The network helps show where Péter Ágoston may publish in the future.

Co-authorship network of co-authors of Péter Ágoston

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Ágoston. A scholar is included among the top collaborators of Péter Ágoston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Ágoston. Péter Ágoston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takácsi‐Nagy, Zoltán, et al.. (2025). Examining the role of elective pelvic radiotherapy in patients Diagnosed with high- and very High-Risk Non-Metastatic prostate cancer. Clinical and Translational Radiation Oncology. 53. 100960–100960.
2.
Nagy, Zoltán Takácsi, et al.. (2025). Reduction of the planning target volume with daily online adaptive radiotherapy in bladder cancer. Strahlentherapie und Onkologie. 201(11). 1162–1169. 1 indexed citations
3.
Székely, Gábor, Péter Ágoston, Tibor Major, et al.. (2025). Assessment of the predictive power the radiation-induced lymphocyte apoptosis method in prostate cancer patients. Scientific Reports. 15(1). 1516–1516. 1 indexed citations
4.
Ágoston, Péter, et al.. (2024). 1592: Dosimetric comparison of adaptive and scheduled plans in adaptive teletherapy of prostate cancer. Radiotherapy and Oncology. 194. S4271–S4272. 1 indexed citations
5.
Fröhlich, Georgina, et al.. (2024). Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires. SHILAP Revista de lepidopterología. 2024. 1–13.
7.
Fröhlich, Georgina, et al.. (2021). Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer. Reports of Practical Oncology & Radiotherapy. 26(2). 196–202. 3 indexed citations
9.
Bonvalot, S., Piotr Rutkowski, Juliette Thariat, et al.. (2018). A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall. Annals of Oncology. 29. viii753–viii753. 9 indexed citations
10.
Sinkovics, István, et al.. (2017). A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary. Pathology & Oncology Research. 23(4). 777–783. 4 indexed citations
11.
Ágoston, Péter, et al.. (2017). Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer. Strahlentherapie und Onkologie. 193(6). 452–458. 7 indexed citations
13.
Ágoston, Péter, et al.. (2014). [Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: side effects caused by the marker implantation].. PubMed. 58(3). 182–7. 2 indexed citations
14.
Bursics, Attila, et al.. (2014). [Surgical treatment of retroperitoneal sarcomas].. PubMed. 58(1). 47–51. 2 indexed citations
15.
Ágoston, Péter, et al.. (2014). [Radiotherapy of soft tissue sarcomas of the extremities and superficial trunk].. PubMed. 58(1). 65–76. 1 indexed citations
16.
Ágoston, Péter, et al.. (2014). [Role of radiotherapy in the treatment of retroperitoneal soft tissue sarcomas].. PubMed. 58(1). 77–82. 3 indexed citations
17.
Ágoston, Péter, et al.. (2014). [Salvage 125I brachytherapy of locally recurrent prostate cancer].. PubMed. 58(3). 219–24. 2 indexed citations
18.
Ágoston, Péter, Tibor Major, Georgina Fröhlich, et al.. (2011). [Permanent implant brachytherapy for early, organ-confined prostate cancer].. PubMed. 55(3). 170–7. 1 indexed citations
19.
Fröhlich, Georgina, Tibor Major, Péter Ágoston, & Csaba Polgár. (2009). High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer in elderly patients (over 65 y.o.). Journal of Contemporary Brachytherapy. 1(3). 183–183. 1 indexed citations
20.
Lengyel, Zsolt, Szabolcs Szakáll, Péter Ágoston, et al.. (2002). [Cost-effective PET scans in oncology].. PubMed. 143(21 Suppl 3). 1255–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026